Elevated serum uric acid is associated with peripheral endothelial dysfunction in women. (November 2019)
- Record Type:
- Journal Article
- Title:
- Elevated serum uric acid is associated with peripheral endothelial dysfunction in women. (November 2019)
- Main Title:
- Elevated serum uric acid is associated with peripheral endothelial dysfunction in women
- Authors:
- Taher, Riad
Sara, Jaskanwal D.
Prasad, Megha
Kolluri, Nikhil
Toya, Takumi
Lerman, Lilach O.
Lerman, Amir - Abstract:
- Abstract: Background and aims: Both elevated serum uric acid (SUA) and peripheral endothelial dysfunction (PED) are associated independently with cardiovascular disease (CVD). However, the association between SUA and PED is yet to be established. We hypothesized that high normal range of SUA is associated with PED. Methods: We performed a retrospective cross-sectional analysis of patients who were referred to Mayo Clinic between 2006 and 2014 for routine cardiovascular evaluation and who underwent evaluation of Reactive Hyperemia Peripheral Arterial Tonometry (index <2 consistent with PED). A high UA was defined as ≥5 mg/dL, in keeping with previous studies evaluating the link between SUA and CVD outcomes. Results: One hundred forty patients were included (mean age 50.7 ± 12.9 years, 86 (61.4%) female). Twenty four patients (17.1%) had pre-existing CVD (8 (9.3%) in females). Thirty patients (21.6%) had a Framingham score > 10% (8 (9.4%) in females). Fifty eight (41.4%) had PED and 77 (55.0%) had an elevated SUA. SUA levels were higher in patients with PED compared to those without (5.5 ± 1.4 vs 4.8 ± 1.2 mg/dL; p = 0.004). In an univariate analysis, elevated SUA levels were associated with PED (Odds Ratio (OR): 2.7; 95% confidence interval [CI] 1.33–5.48; p = 0.005). In a multivariate analysis adjusting for age, sex, presence of obstructive CVD and Framingham score>10, elevated SUA levels were associated with PED (OR 2.45; 95% CI 1.08–5.52; p = 0.031). After stratifyingAbstract: Background and aims: Both elevated serum uric acid (SUA) and peripheral endothelial dysfunction (PED) are associated independently with cardiovascular disease (CVD). However, the association between SUA and PED is yet to be established. We hypothesized that high normal range of SUA is associated with PED. Methods: We performed a retrospective cross-sectional analysis of patients who were referred to Mayo Clinic between 2006 and 2014 for routine cardiovascular evaluation and who underwent evaluation of Reactive Hyperemia Peripheral Arterial Tonometry (index <2 consistent with PED). A high UA was defined as ≥5 mg/dL, in keeping with previous studies evaluating the link between SUA and CVD outcomes. Results: One hundred forty patients were included (mean age 50.7 ± 12.9 years, 86 (61.4%) female). Twenty four patients (17.1%) had pre-existing CVD (8 (9.3%) in females). Thirty patients (21.6%) had a Framingham score > 10% (8 (9.4%) in females). Fifty eight (41.4%) had PED and 77 (55.0%) had an elevated SUA. SUA levels were higher in patients with PED compared to those without (5.5 ± 1.4 vs 4.8 ± 1.2 mg/dL; p = 0.004). In an univariate analysis, elevated SUA levels were associated with PED (Odds Ratio (OR): 2.7; 95% confidence interval [CI] 1.33–5.48; p = 0.005). In a multivariate analysis adjusting for age, sex, presence of obstructive CVD and Framingham score>10, elevated SUA levels were associated with PED (OR 2.45; 95% CI 1.08–5.52; p = 0.031). After stratifying by sex, this association persisted in females only. Conclusions: High normal SUA levels are associated with PED in women who are otherwise at low risk for CVD. Thus, SUA is a promising circulating biomarker that could be used to assist in risk stratification in female patients with chest pain and/or those undergoing evaluation of CVD risk. Highlights: Serum uric acid is associated with microvascular peripheral endothelial dysfunction. Uric acid threshold for vascular health is lower than the upper normal range limit. Uric acid is associated with vascular health in apparently low risk individuals. … (more)
- Is Part Of:
- Atherosclerosis. Volume 290(2019)
- Journal:
- Atherosclerosis
- Issue:
- Volume 290(2019)
- Issue Display:
- Volume 290, Issue 2019 (2019)
- Year:
- 2019
- Volume:
- 290
- Issue:
- 2019
- Issue Sort Value:
- 2019-0290-2019-0000
- Page Start:
- 37
- Page End:
- 43
- Publication Date:
- 2019-11
- Subjects:
- Uric acid -- Peripheral endothelial dysfunction -- Cardiovascular disease
SUA serum uric acid -- PED peripheral endothelial dysfunction -- RH-PAT Reactive Hyperemia Peripheral Arterial Tonometry -- eGFR estimated glomerular filtration rate -- FPG fasting plasma glucose -- FMD flow-mediated vasodilatation -- HBA1C glycated hemoglobin -- T. cholesterol total cholesterol
Arteriosclerosis -- Periodicals
Electronic journals
616.136 - Journal URLs:
- http://www.sciencedirect.com/science/journal/00219150 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/00219150 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.atherosclerosis.2019.07.013 ↗
- Languages:
- English
- ISSNs:
- 0021-9150
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 1765.874000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 17026.xml